1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
